H. B. and N. S. were the topic editors for Whether and How to Anticoagulate Patients with Isolated Distal Deep Vein Thrombosis . M. H. and H. B. were the topic editors for Catheter-Directed Thrombolysis for Acute Deep Vein Thrombosis of the Leg . M. H. and J. V. were the topic editors for Duration of Anticoagulant Therapy . L. M. and C. S. K. were the topic editors for Whether to Anticoagulate Subsegmental Pulmonary Embolism . S. S., T. M. and P. W. were the topic editors for Catheter-Based Thrombus Removal for the Initial Treatment of Pulmonary Embolism . S.W. and T. M. were the topic editors for Choice of Long-Term (First 3 Months) and Extended (No Scheduled Stop Date) Anticoagulant . S. S., S. W. and J. V. were the topic editors for Systemic Thrombolytic Therapy for Pulmonary Embolism . L. M. and P. W. were the topic editors for Aspirin for Extended Treatment of Venous Thromboembolism . L. M. and C. S. K. were the topic editors for Role of Inferior Vena Caval Filter in Addition to Anticoagulation in Patients with Acute Deep Vein Thrombosis or Pulmonary Embolism . E. A. and J. O. were methodologists for the panel. A. B. was the GOC liaison to the panel. L. M. was an overall guideline editor. Financial/non nancial disclosures: The authors have reported to CHEST the following: In the past 3 years, E. A. A. was an author on a number of systematic reviews on anticoagulation in patients with cancer. H. B. has received compensation for participation on advisory committees with speaking engagements sponsored by Sano -Aventis, Bayer Healthcare, and Daiichi-Sankyo. His institution has received grant funding (no salary support) from Daiichi-Sankyo for studying VTE treatment. 